Photo of Rudi Mariën in front of a mico

Rudi Mariën: Biotechnology visionary with assets of over €200 million

Rudi Mariën, a Belgian pharmacist and entrepreneur, has played a decisive role in the development of biotechnology in Belgium. Founder of Innogenetics and a key investor in numerous biotech companies, Mariën has accumulated assets of over 200 million euros. His commitment to innovation and technological development, notably through projects such as Tech Lane Ghent, continues to inspire the biotech sector worldwide.

photo of the Declerck-Allegaert family

Declerck-Allegaert Family: From Family Laboratory to an Empire Worth Over 37 Million Euros

The Declerck-Allegaert family, founders of Klinisch Laboratorium Declerck, have transformed a local business into a major player in healthcare services in Flanders. With advanced technologies and rapid medical results, this laboratory gained notoriety, culminating in its acquisition by Australian giant Sonic Healthcare in 2015. Today, with assets of over 37 million euros, the family continues to stand out for its commitment to the community and quality of care.

Belchim company logo created by Dirk Puttemans in 1987

Putteman family: From Belchim to a 57 million euro fortune in the crop protection industry

Founded in 1987 by Dirk Putteman, Belchim Crop Protection has become a major player in the distribution of crop protection products in Europe. Despite financial challenges and the loss of its founder, the company continues to prosper thanks to strategic partnerships and a strong international presence. The Putteman family, with an estimated fortune of over 57 million euros, embodies innovation and resilience in the agricultural sector. Discover how their heritage and strategy have shaped a world-renowned company.

woman of color analyzing the Medina laboratory of Famille De Raedt-Verheyden

De Raedt-Verheyden family: Colossal 1.7-billion-euro empire in biotechnology

Gino De Raedt and Frederica Verheyden have built a financial empire estimated at over 1.7 billion euros, from a simple medical laboratory in 1978 to major players in European biotechnology. Their journey, marked by strategic acquisitions and a spectacular merger with Biogroup, illustrates an exceptional entrepreneurial vision. With record dividends and diversified investments in real estate and private equity, the De Raedt-Verheyden couple have become one of Belgium's largest fortunes, while preparing for the future with their daughter Ann. Their story embodies the perfect blend of scientific innovation and financial genius.

solvay researcher working for Patrick Solvay

151 Million : Patrick Solvay's Colossal Legacy - From Chemicals to Golf

Immerse yourself in the world of Patrick Solvay, heir to a chemical and financial empire valued at 151 million euros. From major influence in the global chemical industry to ownership of a prestigious golf course, discover how this great-grandson of Alfred Solvay perpetuates and diversifies the legacy of one of Belgium's most influential families.